164 related articles for article (PubMed ID: 7498017)
1. Problems in the treatment of kala-azar: case report.
Nyakundi PM; Rashid JR; Wasunna KM; Were JB; Muigai R; Kirigi G; Mbugua J
East Afr Med J; 1995 Jun; 72(6):406-8. PubMed ID: 7498017
[TBL] [Abstract][Full Text] [Related]
2. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
Pasa S; Toz SO; Voyvoda H; Ozbel Y
Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
[TBL] [Abstract][Full Text] [Related]
3. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
[TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.
Thakur CP; Thakur S; Narayan S; Sinha A
Indian J Med Res; 2008 Jun; 127(6):582-8. PubMed ID: 18765878
[TBL] [Abstract][Full Text] [Related]
5. Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients.
Kager PA; Rees PH; Manguyu FM; Bhatt KM; Wellde BT; Hockmeyer WT; Lyerly WH
Trop Geogr Med; 1984 Mar; 36(1):21-35. PubMed ID: 6328709
[TBL] [Abstract][Full Text] [Related]
6. Observations on the effect of verapamil with sodium stibogluconate in kala azar.
Thakur CP; Kumar M
Trop Geogr Med; 1992 Jan; 44(1-2):15-8. PubMed ID: 1323160
[TBL] [Abstract][Full Text] [Related]
7. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
[TBL] [Abstract][Full Text] [Related]
8. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
[TBL] [Abstract][Full Text] [Related]
9. [A case of antimony resistant kala-azar cured with amphotericin B].
Chen SB; Yang CM; Zhang CJ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
[No Abstract] [Full Text] [Related]
10. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
Karki P; Koirala S; Parija SC; Hansdak SG; Das ML
Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):154-8. PubMed ID: 9740292
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
[TBL] [Abstract][Full Text] [Related]
12. Is one year follow-up justified in kala-azar post-treatment?
Nyakundi PM; Wasunna KM; Rashid JR; Gachihi GS; Mbugua J; Kirigi G; Muttunga J
East Afr Med J; 1994 Jul; 71(7):453-9. PubMed ID: 7828500
[TBL] [Abstract][Full Text] [Related]
13. Ketoconazole in antimonial unresponsive cases of Kala-azar.
Jha TK; Singh NK; Jha S
J Assoc Physicians India; 1995 May; 43(5):347. PubMed ID: 9081966
[No Abstract] [Full Text] [Related]
14. Kala-azar in Uttar Pradesh--a study of 66 patients.
Mittal V; Singh VK; Ichhpujani RL
J Commun Dis; 2002 Mar; 34(1):43-9. PubMed ID: 12718341
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B in resistant kala-azar in Bihar.
Thakur CP; Sinha GP; Pandey AK; Barat D; Sinha PK
Natl Med J India; 1993; 6(2):57-60. PubMed ID: 8477209
[TBL] [Abstract][Full Text] [Related]
16. Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature.
Rybniker J; Goede V; Mertens J; Ortmann M; Kulas W; Kochanek M; Benzing T; Arribas JR; Fätkenheuer G
Int J Infect Dis; 2010 Jun; 14(6):e522-5. PubMed ID: 19726213
[TBL] [Abstract][Full Text] [Related]
17. PCR for diagnosis and assessment of cure in kala-azar patients in Bangladesh.
Salam MA; Mondal D; Kabir M; Ekram AR; Haque R
Acta Trop; 2010 Jan; 113(1):52-5. PubMed ID: 19769932
[TBL] [Abstract][Full Text] [Related]
18. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial of low dosage combination of pentamidine and allopurinol in the treatment of antimony unresponsive cases of visceral leishmaniasis.
Das VN; Ranjan A; Sinha AN; Verma N; Lal CS; Gupta AK; Siddiqui NA; Kar SK
J Assoc Physicians India; 2001 Jun; 49():609-13. PubMed ID: 11584934
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis.
Ramesh V; Kumar J; Kumar D; Salotra P
Indian J Dermatol Venereol Leprol; 2010; 76(2):138-44. PubMed ID: 20228542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
